![Kimberly McCutcheon Jablonski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kimberly McCutcheon Jablonski
Directeur/Membre du Conseil chez
TURG POIN
Profil
Kimberly McCutcheon Jablonski is currently Director at Turning Point Therapeutics, Inc. since 2022.
Since 2024, holds the roles of Secretary, Director & Vice President at Mirati Therapeutics, Inc., Rayzebio, Inc., and Karuna Therapeutics, Inc. Since 2021, serves as Secretary & Director at Bristol-Myers Squibb FCT bêta, Inc. Also holds Director position at Juno Therapeutics, Inc. and President & Secretary at Cardioxyl Pharmaceuticals LLC.
Formerly Secretary & Vice President at Bristol Myers Squibb Co. from 2003 to 2023.
Educated at The University of North Carolina at Chapel Hill with undergraduate and graduate degrees.
Postes actifs de Kimberly McCutcheon Jablonski
| Sociétés | Poste | Début |
|---|---|---|
| TURG POIN | Directeur/Membre du Conseil | 17/08/2022 |
| MIRATI THERAPEUTICS | Directeur/Membre du Conseil | 23/01/2024 |
| RAYZEBIO, INC. | Directeur/Membre du Conseil | 26/02/2024 |
| KARA THER | Directeur/Membre du Conseil | 18/03/2024 |
| JUNO THERAPEUTICS INC | Directeur/Membre du Conseil | - |
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases | President | - |
Anciens postes connus de Kimberly McCutcheon Jablonski
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Compliance Officer | 01/02/2026 |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Directeur/Membre du Conseil | - |
Formation de Kimberly McCutcheon Jablonski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
